Siemens Healthineers (ETR:SHL) received a €39.00 ($45.35) target price from stock analysts at equinet in a report issued on Friday. The brokerage presently has a “neutral” rating on the stock. equinet’s target price would indicate a potential upside of 9.61% from the company’s previous close.
SHL has been the topic of a number of other research reports. JPMorgan Chase & Co. set a €36.90 ($42.91) price target on shares of Siemens Healthineers and gave the company a “neutral” rating in a research report on Friday, July 6th. DZ Bank reaffirmed a “neutral” rating on shares of Siemens Healthineers in a research report on Thursday, August 30th. Sanford C. Bernstein set a €41.00 ($47.67) price target on shares of Siemens Healthineers and gave the company a “neutral” rating in a research report on Tuesday, September 25th. Citigroup set a €42.50 ($49.42) price target on shares of Siemens Healthineers and gave the company a “buy” rating in a research report on Thursday, September 27th. Finally, Oddo Bhf set a €39.00 ($45.35) price objective on shares of Siemens Healthineers and gave the company a “neutral” rating in a report on Friday, September 21st. Thirteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of €38.42 ($44.68).
SHL traded up €0.18 ($0.21) during trading on Friday, reaching €35.58 ($41.37). 581,691 shares of the stock traded hands.
About Siemens Healthineers
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Featured Story: What are retained earnings?
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.